Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06208722 · ClinicalTrials.gov registry record · NA

Testing a Mobile App to Improve Toothbrushing Skills and Habits in Teens With Autism

A NA study of Autism, sponsored by University of Washington.

Recruiting
Registry status
NA
Development phase
270
Enrollment target
1
Study location

NCT06208722: Recruiting NA study of Autism, sponsored by University of Washington.

NCT06208722 is a NA study of Autism that is actively recruiting participants, run by University of Washington. The registered enrollment target is 270 participants, above the 181-participant average among 104 other Autism trials with a reported enrollment target (49% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06208722, a NA study of Autism, is actively recruiting participants, sponsored by University of Washington.

RECRUITING
Registry status
NA
Development phase
270 participants
Enrollment target
1
Study location

Study Summary

The goal of this proposed trial will modify an existing toothbrushing app for teens with autism and compare toothbrushing outcomes with a control app. We have 2 specific aims: * During the 2-year UG3 phase, we will use the Discover, Design+Build, and Test Framework to modify our existing app and pilot the intervention. * During the 4-year UH3 phase, we will recruit 270 pre-adolescents and teens with autism ages 10 to 17 years, randomize participants to one of two arms, and compare outcomes. Participants will asked to use the app, complete surveys on REDCap, participate in feedback interviews and focus groups. Behavior change in the experimental group will be compared with that in the control group.

Primary Outcome

The primary outcome is toothbrushing distribution, defined as the mean proportion of total tooth surfaces in the mouth that are brushed during the last month of the 3-month trial.

Conditions Studied

Interventions

  • BEHAVIORAL Testing a Mobile App to Improve Toothbrushing Skills and Habits in Teens With Autism

Study Locations (1)

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 270 participants
Start Date 2024-01-09
Est. Completion 2029-10-31
Phase NA
University of Washington

1,048 total trials

What NCT06208722 shows while recruiting

NCT06208722 is an interventional study that assigns participants to a tested intervention. The registered 270 participants enrollment target is mid-sized for trials with a published cap, above the 181-participant average among 104 other Autism trials with a reported enrollment target (49% higher).

The record links to 1 condition, with Autism appearing as the primary indexed condition, and to 1 intervention - of which Testing a Mobile App to Improve Toothbrushing Skills and Habits in Teens With Autism is the first listed.

NCT06208722 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT06208722 about?

NCT06208722 is a clinical study titled "Testing a Mobile App to Improve Toothbrushing Skills and Habits in Teens With Autism". The goal of this proposed trial will modify an existing toothbrushing app for teens with autism and compare toothbrushing outcomes with a control app. We have 2 specific aims: * During the 2-year UG3 phase, we will use the Discover, Design+Build, and Test Framework to modify our existing app and pi...

What is the current status of trial NCT06208722?

This trial is currently recruiting. It is a NA study. The enrollment target is 270 participants. The study started on 2024-01-09. Estimated completion is 2029-10-31.

What conditions does trial NCT06208722 study?

This clinical trial studies the following conditions: Autism.

What interventions are being tested in trial NCT06208722?

The interventions under investigation include: Testing a Mobile App to Improve Toothbrushing Skills and Habits in Teens With Autism (BEHAVIORAL).

Who is sponsoring clinical trial NCT06208722?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06208722 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06208722's enrollment target sits among peer trials

270 15th of 104 higher than 90 of 104 other Autism trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Autism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00801489 · 270 participants · Phase 2

    Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

  • NCT04372485 · 270 participants · NA

    Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents

  • NCT04528446 · 270 participants

    The Impact of Glomerular Disorders on Bone Quality and Strength

  • NCT05215327 · 270 participants · Phase 2

    High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06208722, the US trial registry maintained by the National Library of Medicine. NCT06208722 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.